You are here

  • Home
  • Archive
  • Volume 12, Issue 4
  • Total metabolic tumor volume on 18F-FDG PET/CT is a game-changer for patients with metastatic lung cancer treated with immunotherapy

Article metrics

Article menu

This article has a correction. Please see:

Immunotherapy biomarkers
Original research
Total metabolic tumor volume on 18F-FDG PET/CT is a game-changer for patients with metastatic lung cancer treated with immunotherapy

 

Online download statistics by month:

Online download statistics by month: April 2024 to September 2025

AbstractFullPdf
Apr 2024591594122
May 2024218220117
Jun 202418018169
Jul 202416616782
Aug 2024989747
Sep 202410410544
Oct 202415415854
Nov 202416016182
Dec 202415215779
Jan 202515015174
Feb 202525025159
Mar 202514714996
Apr 202513113161
May 202511711749
Jun 2025798530
Jul 2025110
Sep 2025110
Total269927261065